Imaging study of immune activity in healthy volunteers
This study tests a new imaging agent that may help show immune activity in the body using a PET scan. It is being tested in healthy volunteers to see how it behaves and to help plan future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You are in good general health
- You have normal liver and kidney function
- You are willing to use birth control during the study
- You can undergo PET/CT scans
- You have not had recent radiation exposure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to see how a new imaging agent behaves in the body. It is for healthy people to help future research on inflammation.
This study tests a new radioactive dye called [18F]GATT-44 to see how well it can show a specific brain protein on a PET scan. It may help researchers better understand brain conditions in the future.
This early-stage study tests a new PET imaging agent (a radioactive tracer used in medical imaging) to understand how it moves through the body and the radiation dose it delivers. Researchers need healthy volunteers to help establish whether this imaging tool is safe for future patient use.
This study uses a special imaging agent (a radioactive tracer) to see how it works in healthy volunteers and in people with cancer. It may help doctors better understand how cancer behaves and how to target it.
This trial uses a special scan (PET/CT) with an imaging agent that targets a protein called Granzyme B, which is produced by active immune cells. The scan helps doctors see how well immunotherapy is working in your tumor. You may join if you are about to start immunotherapy for a solid tumor and have not had prior cancer treatment.
This study uses a special PET scan to look for a protein called Granzyme B in your body, which may help predict how well treatment will work in T-NK cell lymphoma. It aims to see if this imaging can guide treatment decisions.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.